About Faks
Faks is a company based in Paris (France) founded in 2020. It operates as a SaaS (Software-as-a-Service). Faks has raised $11.44 million across 3 funding rounds from investors including Seedcamp, Speedinvest and FJ Labs. Faks offers products and services including Faks App. Faks operates in a competitive market with competitors including Hospicelink, Rx Redefined, EasyRx, Precal and Promiso Health, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.44 M (USD)
in 3 rounds
-
Latest Funding Round
$5.19 M (USD), Series A
Mar 03, 2025
-
Investors
Seedcamp
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Faks
Faks offers a comprehensive portfolio of products and services, including Faks App.
Facilitates commercial relations between pharmacies and suppliers efficiently.
People of Faks
Unlock access to complete
Funding Insights of Faks
Faks has successfully raised a total of $11.44M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.19 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Faks
Faks has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Seedcamp, Speedinvest and FJ Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in product-focused companies by Connect Ventures.
|
Locked | Locked | Locked | |
|
Venture capital fund investing in tech startups
|
Locked | Locked | Locked | |
|
Venture capital firm focused on marketplaces, gaming, web3, fintech, and multiple sectors
|
Locked | Locked | Locked |
Investor details for Faks
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Faks
Investment portfolio details for Faks
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Faks
Detailed financials for Faks
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Faks Comparisons
Peer comparison for Faks
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Faks
Faks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hospicelink, Rx Redefined, EasyRx, Precal and Promiso Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Web-based DME benefit management is provided for hospice companies.
|
|
| Locked | Locked | Locked |
Supply chain distribution and billing platform provided for healthcare providers.
|
|
| Locked | Locked | Locked |
E-prescriptions for dental practitioners are managed via a specialized platform.
|
|
| Locked | Locked | Locked |
Online prescription management software is provided for scanned data handling.
|
|
| Locked | Locked | Locked |
Digitally enabled at-home diagnostics and care delivery are provided.
|
Detailed competitors of Faks
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Faks
Complete news archive for Faks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Faks
Faks was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Faks is headquartered in Paris, France.
Faks is a funded company, having raised a total of $11.44M across 3 funding rounds to date.
Faks is utilized as a primary tool for enhancing commercial relationships within the pharmacy sector. It is designed to streamline interactions between pharmacies, laboratories, and groupings. Solutions are provided through a mobile and web application that supports pharmacists, pharmaceutical delegates, and laboratory managers in managing supplier relations, handling complaints, expired product returns, and commercial operations. The platform is tailored to improve efficiency, client satisfaction, and business performance across the pharmaceutical supply chain in Europe.
Faks's top competitors include Promiso Health, Rx Redefined and Hospicelink.
Faks offers Faks App.
Faks has 5 investors. Key investors include Seedcamp, Speedinvest, FJ Labs, Connect Ventures, and Cocoa.